Equities Research Analysts’ Updated EPS Estimates for August, 15th (ADL, ASM, BANX, BGEO, DE, GLW, LIN, NTEC, P, PFNX)
Adler Real Estate AG (ETR:ADL) had its buy rating reaffirmed by analysts at DZ Bank AG.
Avino Silver and Gold Mines (NYSEMKT:ASM) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $4.00 target price on the stock.
StoneCastle Financial Corp (NASDAQ:BANX) had its buy rating reaffirmed by analysts at National Securities. National Securities currently has a $23.00 price target on the stock. The analysts wrote, “• BANX posted NII/share of $0.39, a couple cents shy of our $0.41/share estimate but adequately covering the quarterly dividend of $0.37/share. During 2Q17 the company received an A+ rating by Kroll and accordingly lowered the cost of its credit facility to L + 235 bps from L + 285 bps previously and the requirements to maintain $3.5 million of restricted cash was lifted, freeing up more capital to be invested with lower funding costs.
• StoneCastle’s NAV/share saw another quarterly improvement of 0.7% sequentially to $21.47 from $21.32 largely as a result of unrealized appreciation of $920,000 for the quarter pertaining to positive marks on the credit securitization and preferred stock. Asset quality remains very strong with Chicago Shore continuing to be the only non-accrual with a cost of $6.6 million or 3.5% of the portfolio.
• We are revising our 2017 NII/share estimate to $1.60 from $1.61 and our 2018 NII/share estimate to $1.70 from $1.71. “
Bgeo Group PLC (LON:BGEO) had its add rating reissued by analysts at Numis Securities Ltd. The firm currently has a GBX 420 ($5.45) target price on the stock.
Deere & (NYSE:DE) was downgraded by analysts at Bank of America Corporation from a buy rating to a neutral rating.
Corning (NYSE:GLW) was downgraded by analysts at Goldman Sachs Group, Inc. (The) from a neutral rating to a sell rating.
Linde AG (ETR:LIN) had its neutral rating reiterated by analysts at DZ Bank AG.
Intec Pharma (NASDAQ:NTEC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Intec Pharma Ltd. is a biopharmaceutical company. The company focused on developing drugs through proprietary Accordion Pill platform technology. Its product candidates in clinical trial stages consists of Accordion Pill Carbidopa/Levodopa developed for the indication of treatment of Parkinson’s disease symptoms; Accordion Pill Zaleplon is being developed for the indication of treatment of insomnia, including sleep induction and the improvement of sleep maintenance. Intec Pharma Ltd. is based in JERUSALEM, Israel. “
Pandora Media (NYSE:P) had its hold rating reaffirmed by analysts at Wells Fargo & Company.
Pfenex (NYSEMKT:PFNX) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Pfenex Inc. is a clinical-stage biotechnology company developing and commercializing proteins. The company’s lead product candidate is PF582, a biosimilar candidate to Lucentis, for the potential treatment of patients with retinal diseases. It leverages its Pf?nex Expression Technology (TM) platform to build a pipeline of product candidates and preclinical products under development including other biosimilars, as well as vaccines, generics and next generation biologics. Pfenex Inc. is headquartered in San Diego, California. “
Pershing Gold Corporation (NASDAQ:PGLC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Pershing Gold Corporation is engaged in the exploration and development of gold and precious metal properties primarily in Nevada. The Company focuses on the exploration of Relief Canyon properties located in Pershing County in northwestern Nevada. Pershing Gold Corporation is based in Lakewood, Colorado. “
Rio Tinto PLC (NYSE:RIO) was downgraded by analysts at Royal Bank Of Canada from a top pick rating to an outperform rating.
Synopsys (NASDAQ:SNPS) had its positive rating reissued by analysts at Credit Suisse Group. They currently have a $90.00 target price on the stock, up from their previous target price of $82.00.
Symrise Ag (NASDAQ:SYIEY) had its buy rating reissued by analysts at DZ Bank AG.
Tecogen (NASDAQ:TGEN) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $6.00 target price on the stock.
Communications Sales & Leasing,Inc. (NASDAQ:UNIT) was downgraded by analysts at Bank of America Corporation from a buy rating to a neutral rating.
V.F. Corporation (NYSE:VFC) had its hold rating reiterated by analysts at Forward View.
Zynerba Pharmaceuticals (NASDAQ:ZYNE) was downgraded by analysts at Jefferies Group LLC from a buy rating to a hold rating.